Dexcom, Inc. (NASDAQ: DXCM) announced today that the U.S. Food and Drug Administration (FDA) has approved its G5 Mobile CGM ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News FDA Management Comments

Canaccord Genuity Reiterates Buy on DexCom (DXCM) Following FDA Approval of DexCom's G5 Mobile December 21, 2016 10:17 AM FDA Approval of Dexcom’s Non-Adjunctive Indication Triggers a New Era in Diabetes ManagementDecember 20, 2016 4:01 PM